U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H41ClN4O5
Molecular Weight 537.091
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NARONAPRIDE

SMILES

CO[C@H]1CN(CCCCCC(=O)O[C@H]2CN3CCC2CC3)CC[C@H]1NC(=O)C4=C(OC)C=C(N)C(Cl)=C4

InChI

InChIKey=VGDDOIZXGFJDRC-VJTSUQJLSA-N
InChI=1S/C27H41ClN4O5/c1-35-23-15-21(29)20(28)14-19(23)27(34)30-22-9-13-31(17-25(22)36-2)10-5-3-4-6-26(33)37-24-16-32-11-7-18(24)8-12-32/h14-15,18,22,24-25H,3-13,16-17,29H2,1-2H3,(H,30,34)/t22-,24+,25+/m1/s1

HIDE SMILES / InChI
Molecular Formula C27H41ClN4O5
Molecular Weight 537.091
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:13:52 UTC 2023
Edited
by admin
on Sat Dec 16 17:13:52 UTC 2023
Record UNII
058896B00B
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NARONAPRIDE
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
ATI-7505
Code English
ATI7505
Code English
NARONAPRIDE [USAN]
Common Name English
(3R)-1-AZABICYCLO(2.2.2)OCT-3-YL 6-((3S,4R)-4-((4-AMINO-5-CHLORO-2- METHOXYBENZOYL)AMINO)-3-METHOXYPIPERIDIN-1-YL)HEXANOATE
Systematic Name English
1-PIPERIDINEHEXANOIC ACID, 4-((4-AMINO-5-CHLORO-2-METHOXYBENZOYL)AMINO)-3-METHOXY-, 1-AZABICYCLO(2.2.2)OCT-3-YL ESTER, (3S,4R)-
Common Name English
naronapride [INN]
Common Name English
Naronapride [WHO-DD]
Common Name English
Code System Code Type Description
NCI_THESAURUS
C175157
Created by admin on Sat Dec 16 17:13:54 UTC 2023 , Edited by admin on Sat Dec 16 17:13:54 UTC 2023
PRIMARY
ChEMBL
CHEMBL2103858
Created by admin on Sat Dec 16 17:13:54 UTC 2023 , Edited by admin on Sat Dec 16 17:13:54 UTC 2023
PRIMARY
PUBCHEM
11237985
Created by admin on Sat Dec 16 17:13:54 UTC 2023 , Edited by admin on Sat Dec 16 17:13:54 UTC 2023
PRIMARY
DRUG BANK
DB05542
Created by admin on Sat Dec 16 17:13:54 UTC 2023 , Edited by admin on Sat Dec 16 17:13:54 UTC 2023
PRIMARY
CAS
860174-12-5
Created by admin on Sat Dec 16 17:13:54 UTC 2023 , Edited by admin on Sat Dec 16 17:13:54 UTC 2023
PRIMARY
FDA UNII
058896B00B
Created by admin on Sat Dec 16 17:13:54 UTC 2023 , Edited by admin on Sat Dec 16 17:13:54 UTC 2023
PRIMARY
EVMPD
SUB129585
Created by admin on Sat Dec 16 17:13:54 UTC 2023 , Edited by admin on Sat Dec 16 17:13:54 UTC 2023
PRIMARY
INN
9346
Created by admin on Sat Dec 16 17:13:54 UTC 2023 , Edited by admin on Sat Dec 16 17:13:54 UTC 2023
PRIMARY
SMS_ID
100000155491
Created by admin on Sat Dec 16 17:13:54 UTC 2023 , Edited by admin on Sat Dec 16 17:13:54 UTC 2023
PRIMARY
EPA CompTox
DTXSID401006590
Created by admin on Sat Dec 16 17:13:54 UTC 2023 , Edited by admin on Sat Dec 16 17:13:54 UTC 2023
PRIMARY
USAN
WW-117
Created by admin on Sat Dec 16 17:13:54 UTC 2023 , Edited by admin on Sat Dec 16 17:13:54 UTC 2023
PRIMARY
Related Record Type Details
Structure of Naronapride dihydrochloride trihydrate
SALT/SOLVATE -> PARENT
Structure of NARONAPRIDE
EXCRETED UNCHANGED
MAJOR
FECAL
Structure of NARONAPRIDE DIHYDROCHLORIDE
SALT/SOLVATE -> PARENT
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
5-HYDROXYTRYPTAMINE RECEPTOR 4
TARGET -> AGONIST
D(2) DOPAMINE RECEPTOR
TARGET -> INHIBITOR
Structure of NARONAPRIDE
EXCRETED UNCHANGED
MINOR
URINE
Related Record Type Details
Structure of ATI-7400
METABOLITE -> PARENT
URINE
Structure of 1-PIPERIDINEACETIC ACID, 4-((4-AMINO-5-CHLORO-2-METHOXYBENZOYL)AMINO)-3-METHOXY-, (3S,4R)-
METABOLITE -> PARENT
URINE
Structure of (3S,4R)-4-((4-AMINO-5-CHLORO-2-METHOXYBENZOYL)AMINO)-3-METHOXY-1-PIPERIDINEHEXANOIC ACID
METABOLITE -> PARENT
MINOR
URINE
Structure of 1-PIPERIDINEACETIC ACID, 4-((4-AMINO-5-CHLORO-2-METHOXYBENZOYL)AMINO)-3-METHOXY-, (3S,4R)-
METABOLITE -> PARENT
PLASMA
Structure of (3S,4R)-4-((4-AMINO-5-CHLORO-2-METHOXYBENZOYL)AMINO)-3-METHOXY-1-PIPERIDINEHEXANOIC ACID
METABOLITE -> PARENT
PLASMA
Structure of ATI-7400
METABOLITE -> PARENT
PLASMA
Structure of (2S,3S,4S,5R,6R)-6-(2-CHLORO-4-(((3S,4R)-1-(6-HYDROXY-6-OXO-HEXYL)-3-METHOXY-4-PIPERIDYL)CARBAMOYL)-5-METHOXY-ANILINO)-3,4,5-TRIHYDROXY-TETRAHYDROPYRAN-2-CARBOXYLIC ACID
METABOLITE -> PARENT
FECAL; PLASMA; URINE
Structure of (2S,3S,4S,5R,6R)-6-(2-CHLORO-5-METHOXY-4-(((3S,4R)-3-METHOXY-1-(6-OXO-6-((3R)-QUINUCLIDIN-3-YL)OXY-HEXYL)-4-PIPERIDYL)CARBAMOYL)ANILINO)-3,4,5-TRIHYDROXY-TETRAHYDROPYRAN-2-CARBOXYLIC ACID
METABOLITE -> PARENT
Structure of ATI-7400
METABOLITE -> PARENT
FECAL
Structure of NORCISAPRIDE, (+)-
METABOLITE -> PARENT
FECAL; PLASMA; URINE
Structure of (3S,4R)-4-((4-AMINO-5-CHLORO-2-METHOXYBENZOYL)AMINO)-3-METHOXY-1-PIPERIDINEHEXANOIC ACID
METABOLITE -> PARENT
MAJOR
FECAL
Structure of 6-OXO-6-((3R)-QUINUCLIDIN-3-YL)OXY-HEXANOIC ACID
METABOLITE -> PARENT
Structure of 3-QUINUCLIDINOL, (-)-
METABOLITE -> PARENT
FECAL; PLASMA; URINE
Structure of 1-PIPERIDINEACETIC ACID, 4-((4-AMINO-5-CHLORO-2-METHOXYBENZOYL)AMINO)-3-METHOXY-, (3S,4R)-
METABOLITE -> PARENT
FECAL
Related Record Type Details
Structure of NARONAPRIDE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Tmax PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966